首页 | 本学科首页   官方微博 | 高级检索  
检索        


Henagliflozin as add-on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre,randomized, double-blind,placebo-controlled,phase 3 trial
Authors:Jianping Weng MD  Longyi Zeng PhD  Yuwei Zhang MD  Shen Qu MD  Xueying Wang MD  Ping Li MB  Liujun Fu MM  Boqing Ma MM  Shandong Ye MD  Jiao Sun MB  Weiping Lu PhD  Zhiwen Liu MM  Daoxiong Chen BS  Zhifeng Cheng PhD  Haiyan Liu PhD  Tao Zhang PhD  Jianjun Zou PhD
Institution:1. Department of Endocrinology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China;2. Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China;3. Huaxi Hospital of Sichuan University, Chengdu, China;4. Shanghai 10th People's Hospital, Shanghai, China;5. Jinzhou Central Hospital, Jinzhou, China;6. Yuncheng Central Hospital, Taiyuan, China;7. First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China;8. Hebei General Hospital, Shijiazhuang, China;9. Huadong Hospital Affiliated to Fudan University, Shanghai, China;10. First Affiliated Huai'an Hospital of Nanjing Medical University, Huai'an, China;11. Shanghai Xuhui District Central Hospital, Shanghai, China;12. Hainan General Hospital, Haikou, China;13. Fourth Affiliated Hospital of Harbin Medical University, Harbin, China;14. Jiangsu Hengrui Medicine Co., Ltd, Shanghai, China
Abstract:
Keywords:add-on therapy  henagliflozin  metformin  sodium-glucose cotransporter type-2 inhibitor  type 2 diabetes mellitus
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号